dhanalekshmi meenakshi
National University of Sciences and Technology (NUST)
Islamabad, Pakistan
Review Editor
Anti-Cancer Drugs
National University of Sciences and Technology (NUST)
Islamabad, Pakistan
Review Editor
Anti-Cancer Drugs
Autonomous University of Queretaro
Santiago de Querétaro, Mexico
Review Editor
Anti-Cancer Drugs
Martin Luther University of Halle-Wittenberg
Halle, Germany
Review Editor
In silico Methods and Artificial Intelligence for Drug Discovery
Confo Therapeutics
Zwijnaarde, Belgium
Review Editor
Technologies and Strategies to Enable Drug Discovery
Boehringer Ingelheim
Ingelheim, Germany
Review Editor
Anti-Cancer Drugs
Army Medical University
Chongqing, China
Review Editor
Anti-Cancer Drugs
National Scientific and Technical Research Council (CONICET)
Buenos Aires, Argentina
Review Editor
Anti-Infective Agents
The Johns Hopkins Hospital, Johns Hopkins Medicine
Baltimore, United States
Review Editor
Cardiovascular and Hematologic Drugs
Osaka Ohtani University
Tondabayashi, Japan
Review Editor
Anti-inflammatory and Immunomodulating Agents
Conservatoire National des Arts et Métiers (CNAM)
Paris, France
Review Editor
In silico Methods and Artificial Intelligence for Drug Discovery
National Institute of Cancerology (INCAN)
Mexico City, Mexico
Review Editor
Anti-Cancer Drugs
Louisiana State University
Baton Rouge, United States
Review Editor
Anti-Infective Agents
University of Washington
Seattle, United States
Review Editor
Cardiovascular and Hematologic Drugs
University of Kinshasa
Kinshasa, Democratic Republic of Congo
Review Editor
In silico Methods and Artificial Intelligence for Drug Discovery
Loyola University Chicago
Chicago, United States
Review Editor
Cardiovascular and Hematologic Drugs
University of Hradec Králové
Hradec Králové, Czechia
Review Editor
Neurological Drugs